Articles written by STAT - Benzinga

FDA chief: AI adoption driven by financial reasons, not patient benefits

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and

Pfizer's new R&D head, a VC deep-dive, and a new FDA commissioner?

What’s in store for biotech VCs next year? Will Pfizer’s new R&D head do enough to appease investors? And should Adam get a position under the new Food and Drug Administration commissioner? We

STAT+: A documentary about menopause has "misinformation" and shouldn't be used to educate docs, critics say

A dozen experts on women’s health are demanding the Federation of State Medical Boards remove a new documentary about menopause from its continuing medical education program over concerns the movie makes

STAT+: A documentary about menopause has 'misinformation' and shouldn't be used to educate docs, critics say

A dozen experts on women’s health are demanding the Federation of State Medical Boards remove a new documentary about menopause from its continuing medical education program over concerns the movie makes

Squid-inspired replacements for needles; Science Twitter and Bluesky

Good morning, I’m back! And I can barely believe all the news that happened while I was away. On vacation, my biggest concern was a broken milkshake machine at a highway McDonald’s. Why are they always

STAT+: Novartis buys gene therapy startup Kate Therapeutics, joining pursuit of muscular dystrophy treatment

Novartis said Thursday it purchased gene therapy startup Kate Therapeutics for up to $1.1 billion in upfront payments and milestones. It’s a rare buyout for a field that has quieted over the last couple

Versant enters obesity with new startup

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hullo! Today, some squiddy drug delivery, a leukemia deal between Kura Oncology and

STAT+: The state of biotech M&A 2024

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Biotech M&A has been disappointing. Perhaps the

STAT+: Pharmalittle: We're reading about Trump and tariff worries, PBM rules in New York, and more

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite a much-needed spot of rain and the accompanying gloomy clouds hovering over head. After all, we could use a downpour in these

Top FDA official says Trump and RFK Jr. will mean 'vigorous dialogue' on vaccines

LONDON — The incoming Trump administration and its embrace of anti-vaccine figures will give scientists and public health officials the chance to make the case for the value of immunizations, the top vaccine

Opinion: Don't expect RFK Jr. and Dr. Oz to get much done on prevention and wellness

While many critics of Robert F. Kennedy Jr. and Mehmet Oz are focused on their criticisms of vaccines, that focus is somewhat misplaced. The data supporting the safety and efficacy of recommended vaccines is far beyond

STAT+: Bluesky is the new destination for X/Twitter's health and science community. Here's why

Ten years ago, science was entering its extremely online era. On Twitter, some academics, traditionally siloed in their niche fields, were growing unprecedented public profiles. Neil Hall, a genome scientist in the

Opinion: It took years for my Black son to be diagnosed with cystic fibrosis. Then it happened to my family again

Twenty years ago, cystic fibrosis wasn’t a household term for me. Today, cystic fibrosis — a genetic disorder that causes a buildup of thick, sticky mucus that can damage organs, especially the lungs

After youth vaping surge, the U.K. moves to ban disposable e-cigarettes

LONDON — The stacks of brightly colored disposable e-cigarettes, touting flavors like cotton candy ice and greengrape melon and often looming over the not-dissimilar-looking candy displays, have become a

STAT+: The health care industry is girding for Trump's tariffs —and pushing hard for carveouts

President-elect Trump campaigned on imposing broad, steep tariffs to create more jobs in the U.S. and combat China. If enacted, these taxes would send the U.S. health care industry scrambling and could eventually force

STAT+: Top Medicaid official says Republicans' proposed reforms are 'just plain bad policy'

The Biden administration’s outgoing Medicaid chief said on Wednesday that Republican ideas to overhaul Medicaid are “just plain bad policy” and will hurt the program’s low-income

STAT+: Kura licenses leukemia drug to Japanese drugmaker

Kura Oncology has signed a global partnership with the Japanese drugmaker Kyowa Kirin to develop and sell Kura’s experimental treatment for acute leukemia, the companies said Wednesday. Kyowa is paying

STAT+: RFK Jr. wants to blow up the 'corrupt' FDA, but he could Make America Sick Again

Robert F. Kennedy Jr. has a prescription for fixing what he calls the “corrupt” system at the U.S. Food and Drug Administration — blow it up. As far as the controversial gadfly is concerned,

STAT+: RFK Jr. is exploring a plan to upend Medicare's physician payments system

WASHINGTON — People close to Robert F. Kennedy Jr. are exploring a proposal that could upend how physician payment is determined in America, four sources familiar with the process told STAT. Continue to

What to know about Dr. Oz, Trump's pick to head CMS

Good morning. What a newsy week. I’m Isabella Cueto, a chronic disease reporter at STAT, and so it’s my duty to say: Pause. Deep breath. A sip of water would be nice. Maybe a piece of fruit? A short walk